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In vitro sensitization with trinitrophenyl (TNP)'-modified autologous spleen cells has
been shown to generate weak mixed lymphocyte reactions (MLR) (1) and strong cell-
mediated lympholysis (CML) (1-3) . The lysis by cytotoxic effector cells resulting from
such sensitization was directed primarily against TNP-modified cell surface components
controlled by the serological (H-2K and H-2D) regions of the murine major H-2 histocom-
patibility complex (MHC) (3) . Different levels of cytotoxic activity were generated against
TNP-modified products controlled by various alleles of the K and D regions in the four
C57BL/10 congenic lines ofmice investigated . It is well established that the I region ofthe
H-2 complex controls immune response potential to a number ofimmunogens (4) . On the
other hand, the new antigenic determinants resulting from TNP modification which are
detected by CML are controlled by the serological regions of the H-2 complex . Therefore,
the differential levels of cytotoxic reactivity detected could be attributed to H-2-linked Ir
genes expressed in the responding cell population and/or to the relative immunogenicity
of the new antigenic determinants created .
Phenotypic expression of Ir genes controlling responsiveness to many immu-
nogens has been shown to be a dominant characteristic (4) . Thus, by comparing
the responses generated by lymphocytes from high andlow responders with that
generated by lymphocytes from an F, between high and low responder parents
against modified parental and F, stimulating cells, it was possible to determine
the relative contribution of immune response potential and immunogenicity in
the generation of lympholysis . Evidence is presented indicating that the immu-
nogenicity of the new antigenic determinants resulting from TNP modification
of cell surface components controlled by the d alleles of both H-2K and H-2D is
relatively weak in stimulating CML . The presence of k alleles in theK,1-A, and
I-B regions also appears to be associated with the generation ofan even weaker
CML to TNP-modified H-2D1 products . In contrast, the F, responding lympho-
cytes which express K, I-A, and I-B alleles of both parents generated higher
responses . This latter observation is compatible with an additional contribution
of anH-2-linked Ir gene .
Materials and Methods
Mice .
￿
Mice used in the experiments were males, 7-9 wk of age . The B10 congenic strains were
purchased from the Jackson Laboratories, Bar Harbor, Maine . The B10 .A(2R), B10,A(4R), and
'Abbreviations used in this paper : CML, cell-mediated lympholysis ; MHC, major histocompati-
bility complex ; TNBS, 2,4,6-trinitrobenzene sulfonate ; TNP, trinitrophenyl .
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B10.A(5R) recombinant lines were raised in our mouse colony from breeders obtained either from
the Jackson Laboratories or from Dr. Donald Shreffler, Dept. of Human Genetics, Univ. of
Michigan, Ann Arbor, Mich. The A.TL and A.TH mice were raised in our mouse colony from
breeders obtained from Dr. Donald Shreffler.
Trinitrophenyl Modification of Spleen Cells .
￿
Cells to be modified with TNP were prepared
from the spleen ofyoungadult mice as previously described (3). The cell pellet was suspended in a
phosphate-buffered solution containing 10 mM 2,4,6,-trinitrobenzene sulfonate (TNBS) (Pierce
Chemical Co., Rockford, Ill.), pH 7.3 at a vol:vol ratio of cells to reagent of 1:4. The cell reagent
mixture was incubated at 37°C for 10 min andthen washed twicein Hank's balanced salt solution
containing fetal bovine serum. Spleen cells to be used for sensitization and for targets were
modified with TNBS in an identicalfashion. Cellsto be used as cytotoxictargets were labeled with
Na5'CrO, (Amersham/Searle Corp., Arlington Heights, Ill.) for 30 min at 37°C before modification
with TNBS.
In Vitro Cell Culture and Assay for Cytotoxic Effector Cells.
￿
Splenic lymphocytes were sensi-
tized in vitro with TNP-modified cells as previously described (1). The culture medium was
supplemented with 5 x 10-5 M 2-mercaptoethanol. After a 5-day sensitization period, effector cells
were harvested, their cytotoxic reactivity determined, and the mean and standard error of the
percentage of specific lympholysis was calculated as described elsewhere (1). The effector:target
cell ratio used was 20 :1 throughout these experiments. Nonspecific lysis of TNP-modified, 51C,
labeled splenic target cells was 15-32%, which was subtracted from the total lysis to obtain the
specific lympholysis.
Results
An earlier study indicated that B10.A effector cells generated by sensitizing
B10.A responding lymphocytes with TNP-modified autologous spleen cells ex-
hibited stronger reactivity to TNP-modified K-end products than to modified D-
end products (3). In contrast, B10.D2 effector cells in the TNP autologous CML
system generated equal reactivity to altered K and D products (3). The results
presented in Table I extend and verify this observation. B10.A effector cells
lysed B10.A-TNP and B10.BR-TNP target cells but not B10.D2-TNP targets,
although B10 .D2 shares I-C, S, and D regions with 1310.A . However, effector
cells from B10.D2 donors sensitized with modified B10 .D2 spleen cells lysed
B10.A-TNP targets (which share the same I-C, S, and D allelles) as well as the
syngeneic B10.D2-TNP targets . This indicates that the modified d alleles of the
D-end serve as adequate target antigens for lympholysis. B10.A lymphocytes
were sensitized against BlO.D2-TNP stimulating cells in order to determine
whether the failure of B10.A responding cells to generate activity to the D-end
was due to a failure ofresponse potential or to weak immunogenicity of the new
antigenic determinants resulting from modification of H-2D" on the B10 .A
spleen cells. Sensitization of B10.A responding lymphocytes with B10.D2-TNP
stimulating cells resulted in enhanced CML tested on B10 .A-TNP targets.
However, the same effector cells lysed TNP-modified 1310 .1311 targets which
share no known H-2 private specificities with the B10 .D2 stimulating cells. This
result raised the possibility that allogeneic sensitization could lead to effector
cells which would nonspecifically lyse any TNP-modified target. This possibility
was tested by sensitizing BlO.A responding lymphocytes with unmodified
B10.D2 spleen cells. The results (also shown in Table 1) indicate that sensitiza-
tion with unmodified allogeneic stimulating cells generates effector cells which
can lyse TNP-modified target cells syngeneic with the responder. Additional
data extending this point and illustrating that TNP-modified splenic targets not
syngeneic with either the responding or stimulating cells can be lysed by effector916 H-2 LINKED CONTROL OF CML TO TNP-MODIFIED H-2 PRODUCTS
TABLE I
Differential Cytotoxic Activity Generated by B10.A andB10.D2 Responding Cells to
TNP-Modified Products of the d Allele of H-213
cells generated by allogeneic sensitization are summarized in Table 11. These
results indicate that the question of weak immunogenicity of new antigenic
determinants resulting from TNP modification of H-2 products cannot be ap-
proached by introducing allogeneic, modified stimulator cells. Furthermore,
experimental protocols involving allogeneic sensitization cannot be used for
investigating the specificity involved in the TNP-modified CML.
Respond-
ing cell Stimulating cell Target cell Specific lysis
TNP-modified tar-
get cell H-2 region
common to stimu-
lating cell
Responding cell
H-2 region alloge-
neic toboth stimu-
lating and target
cell
- SE
1310.A 1310.A-TNP BlO.A-TNP 33.4 - 2.3 All of H-2 None
kkkddd kkkddd-TNP kkkddd-TNP
Bl0.D2-TNP -3.7 - 4.0 I-C, S, D None
dddddd-TNP
B10.BR-TNP 25.8 - 4.0 K, I-A, I-B None
kkkkkk-TNP
B10.D2-TNP B10.A-TNP 22.7 - 2.2 I-C, S, D None
dddddd-TNP kkkddd-TNP
B10.D2-TNP 23.3 - 4.1 All of H-2 K, I-A, I-B
dddddd-TNP
B10.BR-TNP 12.3 - 2.8 None None
kkkkkk-TNP
1310.132 B10.A-TNP 17.1 - 2.2 None None
dddddd kkkddd-TNP
B10.D2-TNP 30.4 - 5.1 None K, I-A, I-B
dddddd-TNP
B10.BR-TNP 10.2 - 2.1 None None
kkkkkk-TNP
1310.132 B10.D2-TNP B10.A-TNP 12.8 - 2.2 I-C, S, D None
'dddddd dddddd-TNP kkkddd-TNP
B10.D2-TNP 11 .2 - 1.9 All of H-2 None
dddddd-TNP
B10.BR-TNP 5.0 " _ 3.0 None None
kkkkkk-TNP
B10.A-TNP BlO.A-TNP 44.4 - 0.6 All ofH-2 K, I-A, I-B
kkkddd-TNP kkkddd-TNP
B10.D2-TNP 15.4 - 3.5 I-C, S, D None
dddddd-TNP
B10.BR-TNP 33.3 ± 3.2 K, I-A, I-B K, I-A, I-B
kkkkkk-TNP
1310.A B10.A-TNP 50.7 t 1.3 None K, I-A, I-B
kkkddd kkkddd-TNP
B10.D2-TNP 8.1 - 1.0 None None
dddddd-TNP
B10.BR-TNP 35.3 - 2.4 None K, I-A, I-B
kkkkkk-TNPANNE-MARIE SCHMITT-VERHULST AND GENE M. SHEARER
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TABLE II
Specificity ofTargetLysis by Spleen Cells Sensitized Against Modified Syngeneic or
Unmodified Allogeneic Cells
Target cells
It was also observed in Table II that effector cells generated by sensitization of
1310 .A responding lymphocytes with C57BL/10 and with 1310 .D2 spleen cells
significantly lysed to a lesser extent MOM and C57BL/10 targets, respectively.
Since the only known common H-2-associated specificity shared between
C57BL/10 and MOM and not expressed in B10.A is Ia8 (5), the possibility must
be considered that the weak CML detected may have been to this I-region
product. Anotherpossibility is that a yet undescribed public specificity is shared
between b and d alleles of the K region (Sachs, D., personal communication).
Similar results were obtained using B10.BR responding cells (lower part of
Table II). However, in this case the CML could also have been directed against
the H-2D public specificities 6, 27, 28, and 29 (6).
In order to determine whether the negative or very weak CML generated by
B10.A responding lymphocytes to the TNP-modified cell surface components
controlled by H-2D' were due to a responding cell defect (possibly controlled by
H2-linkedIr genes), responding lymphocytes from (1310 .A x B10.D2)F, donors
were sensitized with TNP-modified F,, 1310 .A, or B10.D2 stimulating cells. The
effector cells generated were assayed on modified and unmodified B10.A and
MOM target spleen cells. The results are summarized in Table III. In Exp. 1,
(1310 .A x B10.D2)F, responding cells generated from 36.9 to 40.6% lympholysis
toward modified H-2K' products when sensitized with either modified F, or
1310 .A stimulating cells. These data are comparable to the lysis obtained from
effector cells generated by sensitization of B10.A splenic lymphocytes with
modified syngeneic cells assayed on B10.A-TNP targets (see Table I) . Effector
B10.BR
Unmodified
(kkkkkk)
-TNP
C57BL/10
Unmodified
(bbbbbb)
-TNP
BlO.D2
Unmodified
(dddddd)
-TNP
1110.1311 B10.BR-TNP 1 .1-0.7 38.5-1.1 0.2-0.9 9.7-1.5 3.0-0.7 6.7-1 .5
kkkkkk kkkkkk-TNP
C57BL/10 0.8-0.9 15.2-1.4 30.4-1.5 37.2-1.4 16.5-1 .0 22.6-3 .3
bbbbbb
BlO.D2 0.3-1 .2 23.1-1.8 8.5-1.0 19.8-1.1 41.4-2.1 38.9-2.1
dddddd
Re
spond-
ing cell
Stimulating
cell B10.A
Unmodified
(kkkddd)
-TNP
C57BL/10
Unmodified
(bbbbbb)
-TNP
BlO.D2
Unmodified
(dddddd)
-TNP
%tSE %=SE %-SE
B10.A B10.A-TNP -1.9-1.5 36.1-1 .5 1.0-0.9 7.0-2.0 -2.2-1.2 7.9-2.5
kkkddd kkkddd-TNP
C57BL/10 0.3-1.4 11.9-1.6 34.9-3.1 37.5-2.5 6.2-0.9 14.6-3.9
bbbbbb
1310.D2 3.7-1.1 11.7-0.7 11.5-0.9 13.9-1.9 28.7-1.2 38.0-2.0
dddddd918
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cells generated by sensitization of F, lymphocytes with B10 .A-TNP stimulating
cells produced 17.4% lysis to the modified H-2Dd products as assayed on B10.D2-
TNP targets. This is the same level of lympholysis that was obtained when
identical F , responding lymphocytes were sensitized with B10. D2-TNP stimulat-
ing cells and assayed on B10.A-TNP target cells. The latter reaction also detects
CML directed toward modified H-2Dd products. These levels of reactivity gener-
ated by (B10.D2 x B10.A)F 1 lymphocytes directed against modified H-2Dd
products are similar to those obtained from B10.D2 responding cells toward the
modified syngeneic H-2D' products (12.8%, Table 1), but contrasts to those
obtained by sensitization of B10.A responding lymphocytes with modified Synge-
neic cells assayed on B10.D2-TNP targets (-3.7%, Table I). Similar results are
shown in Exp. 2 and 3, Table 111. The negative controls assayed on unmodified
parental targets indicated that no F, antiparent CML was detected in these
experiments. The different reactivities generated toward the modified H-2D'
products by B10.A and B10 .D2 responding lymphocytes cannot be attributed to a
weaker immunogenicity of the modified H-2D1 products expressed on B10.A as
compared with B10.D2 stimulating cells, but appears to be due to a responder
cell defect in the B10.A strain, which is expressed as a dominant trait in the F , .
Responding lymphocytes from (B10.D2 x B10.A)F, donors generated CML
toward modified H-2K' products in the range of 35-40% lysis. In contrast,
identical responding cells generated CML toward modified H-2K' and H-21)' in
the range of 15-20% lysis. This observation raised the possibility that TNP-
modified products controlled by d alleles mapping in the K and D serological
regions were less immunogenic than the TNP-modified k allele ofH-2K. To test
this possibility, the same pool of (B10A x B10.D2)F, responding lymphocytes
were sensitized by modified F,, B10.A, or B10.D2 stimulating cells, and the
resulting effectors assayed on a common modified (B10A x B10 .D2)F, target.
The results, shown in Table IV, verify that the new antigenic determinant
formed by TNP-modification of H-2K'` products are more immunogenic than
those formed by modification of H-2K' products. In this case, no differential
contribution to immunogenicity could have been made by modified D-end prod-
ucts, since the modified H-2D' products were common in both immunogens. A
comparison of the levels of cytotoxicity generated by F,, B10.A, or B10.D2
lymphocytes against SJL alloantigens (lower part of Table IV) verified that the
CML to TNP-modified autologous H-2 products is about as strong as that to
alloantigens (7) . Furthermore, equal responses were obtained to the SJL alloan-
tigens with all three strains of responding cells, despite the fact that differential
levels of lympholysis were obtained in the various combinations for TNP-
modified autologous reactions .
In an earlier report, effector cell specificity generated in the TNP-autologous
system was demonstrated in four C57BL/10 congenic strains to be directed
toward modified products mapping in or near the K and D serological regions (3,
7). The results shown in Table V and VI extend the previous data to include
modified autologous CML reactions using the two B10.A recombinants
B10 .A(4R) and B10W5R), as well as [B10.A(4R) x B10 .A(5R)]F, . This pair of
recombinants is of particular interest in that it introduces new combinations of
K and D alleles for comparison of cytotoxicity levels with previous examples .920
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TABLE IV
Differences in Immunogenicities of TNP Modified B10 .A and Modified B10.D2 Cells
Stimulating (B10 .A x B10 .D2)F,, B10.A, or B10.D2 Lymphocytes and Absence of
Differential Reactivities Toward the H-2' Alloantigens
Furthermore, the CML specificities generated can be more diverse due to the
greater polymorphism of the K and D region of the (4R x 5R)F, .
Responding lymphocytes from B10.A(4R) donors sensitized with TNP-modi-
fied autologous spleen cells generated effector cells specific for modified D-end as
well as modified K-end H-2 products (Table V). Both B10 .BR-TNP and B10.A-
TNP targets were as effective as modified syngeneic targets in detecting lympho-
lysis . This indicates CML specificity to altered K or I-A products. The negative
results obtained with A.TL-TNP targets indicates that the K-end specificity is
directed toward altered products controlled by K alone or by K plus I-A.
C57BL/10-TNP targets were also effective in detecting lysis by 411 effector cells .
This indicates specificity toward the products of a region or regions to the right
of I-A-which could be H-2D . The I-B region can be excluded, since the
B10.A(5R)-TNP target was not lysed. The 11.9% lysis obtained with the
B10.HTG target was lower than expected if the 27.1% lysis detected with B10-
TNP targets were directed exclusively toward modified H-2D products . Never-
theless, the data obtained using the modified B10.HTG target indicates that a
portion of the lytic specificity was directed to altered cell surface components
controlled by H-2D. Responding splenic lymphocytes from B10 .BR donors sensi-
tized with modified autologous spleen cells are also included in this experiment
for comparison with the 411 results (Table V). The results verify those reported
previously (3, 7), and are similar in magnitude for modified H-2K' products to
that obtained with 411 responding cells. It is noteworthy that the 4R responding
lymphocytes generated effector cells to autologous modified H-2D products,
whereas B10 .BR responding lymphocytes did not.
Responding cell Stimulating cell Target cell
Specific
Exp. I
lysis
Exp. 2
%-SE
(B10.A x B10.D2)F, (B10.A x B10.D2)F,-TNP (B10.A x B10.D2)F,-TNP 33.6 - 4.1 31.4 - 6.8
kkkddd-TNP kkkddd-TNP
dddddd-TNP dddddd-TNP
B10.A-TNP 37.1 ~- 2.9 26.0 - 3.9
kkkddd-TNP
B10.D2-TNP 10.4 ± 1.9 18.3 - 3 .0
dddddd-TNP
B10.A B10.A-TNP 31.9 ± 3.9 31 .5 - 1.7
kkkddd-TNP
B10.D2 B10.D2-TNP 11.9 - 3.6 17.4 - 1.6
dddddd-TNP
(B10.A x B10.D2)F, SJL SJL 30.5 t 4.0 NT
ssssss ssssss
B10.A 30.7 - 2.7 NT
B10.D2 33.0 - 2.9 NTResponding
cell
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In vitro Induction of Cell-Mediated Lympholysis in B10.A5R and BIO.A4R
Recombinants, and in B10 .BR Spleen Cells to TNP-Modifted Syngeneic Lymphocytes
Stimulating cell
TABLE V
Target cell
￿
Specific lysis
Target cell H-2 re-
gion common to re
sponding and stimu-
lating cells
- SE
B10.A4R B10.A4R-TNP BIO.A4R-TNP 47.1 +_ 4.1 All ofH-2
kkbbbb kkbbbb-TNP kkbbbb-TNP
B10.BR-TNP 45.4 " 5.1 K, I-A
kkkkkk-TNP
BlO.A-TNP 31.9 - 2.8 K, I-A
kkkddd-TNP
ATL-TNP 5.5 - 2.6 I-A
skkkkd-TNP
Bl0.A5R-TNP 5.6 - 1.7 1-B
bbbddd-TNP
C57BL/10-TNP 27.1 - 3.3 I-B, I-C, S, D
bbbbbb-TNP
B10.HTG-TNP 11.9 - 2.4 D
dddddb-TNP
B10.D2-TNP 0.6 _- 2.8 None
dddddd-TNP
(B10.A4R x B10.A5R) 43.4 - 2.3 All ofH-2
F,-TNP
kkbbbb-TNP
bbbddd-TNP
B10.BR 1310.13R-TNP B10.BR-TNP 30.0 - 3 All ofH-2
kkkkkk kkkkkk kkkkkk-TNP
B10.A-TNP 32.3 " _ 4.3 K, I-A, 1-B
kkkddd-TNP
C3H.OH-TNP 2.8 " 2.2 D
dddddk-TNP
B10.D2-TNP 1 .0 - 0.9 None
dddddd-TNP
B10-TNP 6.1 ± 2.7 None
bbbbbb-TNP
B10.A5R B10.A5R-TNP B10.A5R-TNP 19.0 " _ 2.2 All ofH-2
bbbddd bbbddd bbbddd-TNP
C57BL/10-TNP 16.6 - 3.0 K, I-A, 1-B
bbbbbb-TNP
B10.A4R-TNP -0.11 - 1.9 I-B
kkbbbb-TNP
B10.D2-TNP 13.9 " _ 1.8 I-C, S, D
dddddd-TNP
B10.HTG-TNP 1.7 - 1.5 I-C, S
dddddb-TNP
B10.BR-TNP 8.1 - 2.5 None
kkkkkk-TNP
(B10.A4R x B10.A5R)-TNP 14.2 - 1.2 All ofH-2
kkbbbb-TNP
bbbddd-TNP922
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TABLE VI
In Vitro Induction of Cell-Mediated Lympholysis in (B10.A4R x BIO .A5R)F,
Lymphocytes to TNP-Modified Syngeneic Spleen Cells
The CML responses generated by sensitizing B10.A(5R) with TNP-modified
autologous cells are summarized in the lower part of Table V. In general, the
magnitude of lytic responses were lower than that observed using 4R cells .
B10.A(5R) effector cells lysed both B10-TNP and B10.1)2-TNP targets as well as
modified syngeneic targets, indicating that equivalent lytic responses were
generated to altered products ofthe K, I-A, I-B regions and theI-C, S,D regions
of H-2 . That modified products of the I-B or I-C, S regions could have been
effective targets alone was excluded by the absence of lysis on B10.A(4R)-TNP
and B10.HTG-TNP targets . A weak but insignificant response was detected
using B10.BR-TNP targets which share no known major H-2 regions with the
stimulating cells . The lower magnitude of lysis of B10.A(5R) effectors when
compared with B10.A(4R) effectors assayed on (4R x 5R)F,-TNP targets, which
express all fourKandD alleles, indicates a weaker level of sensitization of the
B10.A(5R) responding cells.
Since the (4R x 5R)F , lymphocytes express cell surface components controlled
by all four of the K and D alleles contributed by the parental strains, TNP-
modification of (4R x 5R)F, spleen cells should result in the formation of a
greater diversity of altered self antigens . To test this possibility, (4R x 5R)F ,
splenic lymphocytes were sensitized with TNP-modified autologous spleen cells .
The effector cells generated were assayedon a number of modified congenic and
recombinant target spleen cells (Table VI) . TNP-modified F 1 and both the
modified B10.A(4R) and B10.A(5R) target cells were lysed by F, effector cells .
However, the extent of lysis of the B10.A(5R) targets was not as high as that
obtained with the F, and B10.A(4R) targets, although it was equal to the lysis
Responding cell Stimulating cell Target cell Specific lysis
Target cell H-2 re-
gioncommon to re-
spondingand stim-
ulating cells
%, - SE
(BIO.A4R x (B10.A4R x (B10.A4R x 35 .9 = 3.2 All ofH-2
B10.A5R)F, BlO.A5R)F,-TNP BlO.A5R)F,-TNP
kkbbbb kkbbbb
bbbddd bbbddd
Bl0.A4R-TNP 39 .4 :t 2.7 All ofH-2"'
kkbbbb
B10.A5R-TNP 22 .7 - 3.0 All ofH-2'
bbbddd
C57BL/10-TNP 19 .5 - 2.2 All ofH-2°
bbbbbb
B10.BR-TNP 41 .5 - 1 .2 K, I-A
kkkkkk
B10.D2-TNP 20 .2 - 1 .2 (I-C, S, D)°
dddddd
B10.HTG-TNP 15 .4 - 3.0 (I-C, S)°, D°
dddddbANNE-MARIE SCHMITT-VERHULST AND GENE M . SHEARER
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produced by B10 .A(5R) effectors (Table V) . The lysis of B10.BR-TNP, B10.D2-
TNP, and B10.HTG-TNP by (4R x 5R)F, effector cells detected specificities to
modified self components controlled by H-2K', H-2Dd, and H-2Db, respectively .
The extent of lysis obtained by the F, effector cells for each specificity was
similar to that observed by the parental strain expressing the specificity de-
tected on a given target . These results demonstrate that a greater number of
distinct new antigenic specificities are created as a result ofTNP modification of
H-2 products ofF, lymphocytes (at least three) than of inbred parental lympho-
cytes (only two) .
Discussion
Since the recent independent discoveries that viruses (8-12), and chemicals
(1-3) can alter cell surface products controlled by the serological regions of the
H-2 complex to create new cell-bound antigens, a potentially relevant autolo-
gous function has been ascribed for the structural antigens controlled by the
MHC (3) . Hence, lymphocytic choriomeningitis (8-10), ectromelia (11), and
vaccinia (12) viruses, and trinitrobenzene sulfonate (1, 3, 7) modified cells stimu-
late syngeneic (or autologous) lymphocytes to generate thymus-derived effector
cells capable of lysing only target cells which are modified by the same agent
and which express commonK orD serological regions with the modified stimu-
lator cells .
It was previously observed that effector cells generated by TNP-autologous
sensitization of B10.A lymphocytes did not appreciably lyse TNP-modified
splenic targets expressing common D-end antigens, although they did effec-
tively lyse modified common K-end targets (3, 7) . In contrast, B10 .D2, which
expresses the same I-C, S, and D, but different K, I-A, and I-B alleles responded
to both TNP-modified K and D products (3, 7) . Thus, there was a differential
effect on the response to TNP-modified H-2D° , which was not directly associated
with the region controlling the antigen itself, but was influenced by alleles in
the "left half" ofH-2 (K, I-A,1-B) . This could have been due to : (a) an H-2-linked
Ir gene controlling response potential and mapping in one of the known I
regions ; or (b) an influence of the new antigenic determinants created by
modification ofK-end products on the immunogenicity of modified components
controlled by the D-end .
By sensitizing B10.A lymphocytes with B10.D2-TNP stimulating cells, at-
tempts were made to test the relative immunogenicity of TNP-modified H-2D`'
products without the possible effects of altered antigens controlled by H-2K' . As
shown in Tables I and II, however, semiallogeneic or allogeneic CML reactions
with unmodified stimulating cells generated effectors which lysed to a variable
extent (8.1-23.1%) any TNP-modified target spleen cell . This observation illus-
trates the importance of using only syngeneic mixtures of responder and stimu-
lating cells in the sensitization phase of the CML . Thus, experiments designed
to test "TNP-hapten-specific" CML by this protocol (13) can lead to lysis of
"hapten-modified" targets, which, however, is unrelated to the presence of the
"hapten" on the stimulating cell . The mechanism of this nonspecific lysis is
unknown .
The results summarized inTable III demonstrate that F, responding lympho-924
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cytes can generate equivalent CML responses specific for modified H-2D" prod-
ucts when sensitized either with B10.A or B10.D2 stimulating cells modified
with TNP. The levels of lympholysis detected ranged from 12 .4 to 20 .0% using F,
effectors, which were indistinguishable from the levels of lysis produced by
B10.D2 effectors toward modified D-end products (12.8-19.2%) (3, 7), but higher
than that by B10.A (-3 .7-5.2%). These results indicate that the new cellular
antigens resulting from TNP modification of H-2D" products are expressed to
the same extent on B10.A and B10.D2 spleen cells. Furthermore, the lack of a
CML response in the B10.A to this new antigenic specificity appears to be due to
a responding cell defect which is associated with genes mapping in the K, I-A, or
I-B regions of the MHC. This effect may be attributable to an Ir gene, which is
expressed as a dominant trait by a d allele in the relevant I or K region.
A genetic defect in cellular immunity controlled by the MHC can be visualized
either as a control by that region on the repertoire of T-cell receptors specific for
new cellular antigens, i.e ., on the available clones, or as a defect at the level of
the cooperation of two cell populations known to act synergistically in the
generation of cytotoxic effector cells (14, 15). The expression of the genetic defect
at the level of cell-to-cell interaction could be analogous to that suggested for the
mechanism of action of Ir genes controlling antibody production to thymus-
dependent antigens (16, 17). A distinction between these two alternatives has
not yet been realized.
Genetic control of T-cell-mediated immunity in the mouse has been recently
reported for stimulation of thymidine incorporation (18, 19) and delayed hyper-
sensitivity to the multichain synthetic polypeptide POIYL(Tyr,Glu)-POIYDLAla--
polyLLys2 which is under H-2-linked genetic control (20), cell-mediated lymphol-
ysis to P-815 mastocytoma (21), and for delayed hypersensitivity to contact
sensitization with picryl chloride (22) . In contrast to what is shown in the
present report, responsiveness to picryl chloride was recessive. Furthermore,
Shultz and Bailey presented evidence suggesting that distinct genes mapping at
either end of H-2 influenced responsiveness (22). Similar effects of genes at both
ends of the MHC has been demonstrated for responsiveness to autoimmune
thyroiditis (23). Thus, in addition to a gene mapping in the K-end ofH-2, other
loci located at the D-end or outside of H-2 were observed to modify responsive-
ness in autoimmune thyroiditis (23).
These two independent observations that distinct genes mapping in the K-
nd D-ends of the MHC appear to influence H-2-linked immune responsiveness
can be accounted for by assuming that conventional Ir genes mapping in the
known I-regions are responsible for the K-end influence or responsiveness. The
D-end association could be accounted for by at least two mechanisms. First, it is
possible that a separate region mapping near the D region of the murine MHC
also expresses Ir genes. Alternatively, it is possible that the D-end products are
involved in the formation of new antigenic determinants resulting from the
modification of self-antigens relevant for the generation of autoimmune reac-
tions . The results presented in this report (Tables IV, V, and VI) suggest that
z Davis, Stephen, Gene M. Shearer, Edna Mozes, and Michael Sela. 1975. Genetic control ofthe
murine cell-mediated immune response in vivo. H. H-2 linked responsiveness to the synthetic
polypeptide poly(Tyr,Glu)-poly (DLAla)--poly(Lys). Manuscript submitted for publication.ANNE-MARIE SCHMITT-VERHULST AND GENE M. SHEARER
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different levels ofimmunogenicity are generated by TNP modification ofdistinct
alleles of the K- and/or D-region products of the MHC . Within the C57BL/10
background, more effective generation of effectors was achieved with sensitiza-
tion of (B10.A x B10.D2)F 1 responding cells by modified K'` products than by
modified Kd or Dd products (Table IV). A similar intermediate level of lymphol-
ysis was generated toward the H-2D' modified products by the BlO .A(5R)
responder, which introduces b alleles in the K, 1-A, and I-B regions (Table V) .
Unlike the examples of selective reactivity toward the modified K' products of
B10.A and BlO.BR (3), a strong CML both to modified H-D and H-2K products
can be obtained, as shown in Table V with B10.A(4R). Since differences between
these congenic and recombinant strains involved both the immunogen (modified
b allele of H-2D) andI-A, I-B, I-C, and S region alleles, the relative importance
ofthe two potential influences on the generation of response toward modified H-
2D products is being studied.
The data summarized in Table VI indicate that TNP-modification of
[B10 .A(4R) x B10.A(5R)]F, spleen cells results in the formation of at least three
distinct new antigenic specificities, i.e., modified products of H-2K', 11-21)', and
H-2D°. Thus, the F, cells, which express greater polymorphism than the paren-
tal cells, also generate more new specificities upon modification of cell surface
components . Polymorphism at the MHC has been assumed to have a selective
advantage in nature (24). Since products of the serological regions of the H-2
complex appear to serve as cell surface components which can be modified
chemically (1, 3, 7) or by viruses (8-11) to form new cellular antigenic specifici-
ties, it has been postulated that H-2 polymorphism would provide a greater
number of cell surface structures susceptible to alteration and formation of new
antigens (3, 25). Such a mechanism could be advantageous for surveillance
against viral induced neoplasia, but disadvantages in autoimmunity.
Since modified H-2K and modified H-2D products are involved in the forma-
tion of new cellular antigens and since the responses to these modified self
antigens appear to be controlled by H-2-linked Ir-like genes, it may be predicted
for those cases in which autoimmune-like phenomena are involved in mouse (1-
3, 8-12, 13) and in man (26), that some degree of regulation of immunity will be
effected by Ir region genes as well as by genes mapping in or near both
serologically defined regions, which control the cell surface relevant for altered
self.
Summary
Murine thymus-derived lymphocytes can be sensitized in vitro to trinitro-
phenyl (TNP)-modified autologous spleen cells (1, 2). Cytotoxic effector cells
were generated which were specific for TNP-modified target cells expressing the
sameH-2K and H-2D serological regions as the modified stimulator cells (3, 7) .
Spleen cells from two C57BL/10 congenic strains of mice sharing common I-C, S,
and D regions, but differing at K, I-A, and I-B regions, generated different
levels of lytic responses to the shared modified H-2D' products upon sensitiza-
tion with autologous TNP-modified cells. Lymphocytes from an F, between
responder and nonresponder strain generated a level of cytolysis toward the H-
2Dd modified specificity which was of the same order of magnitude as that926
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obtained with the high responder, irrespective of whether F, or either parental
strain of modifed stimulator cell was used . These results suggest that the
modification of H-2Dd products resulted in formation ofnew antigenic determi-
nants in both parental strains . However, the difference observed in responsive-
ness appeared to be due to a gene or genes mapping in the K, I-A, or I-B region
which influenced the ability of the responding lymphocytes to react to these
modified H-2D d products . Responsiveness was expressed as a dominant trait in
the F , .
It also appeared that within the C57BL/10 background differences in immuno-
genicity were detected among the various new antigenic determinants formed
by TNP modification, depending on the alleles expressed in the K and D
serological regions . Modified H-2K' products were more immunogenic than
modified H-2K1 or modified H-2D' products, when used as stimulators of (B10.A
x B10 .D2)F , respondinglymphocytes . Furthermore, these F, lymphocytes gener-
ated a broader spectrum of responses to modified autologous components than
did either parental strain . The possibility is raised thatH-2 polymorphism may
have a selective advantage both in terms of the library of Ir genes available for
responding to and in the formation of a greater spectrum of new cell-bound
antigenic specificities in those systems in which autologous H-2 modified prod-
ucts serve as immunogens . The results of this report imply bifunctional H-2-
linked regulation of a T-cell-mediated immunity in the response potential toand
in the formation ofnew modified self antigens .
Received for publication 23 June 1975 .
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